(4-((4-Methylpiperidin-1-yl)sulfonyl)phenyl)boronic acid, 98%, 100mg

MBX2329, 50mg

Ethyl 2-{[3-chloro-5-(trifluoromethyl)-2-pyridinyl]amino}acetate, 95.0%, 250mg

(1R,2S)-N-Benzyl-2-amino-1,2-diphenylethanol, 98.0%, 5g

Acetic acid, (2-methoxyphenoxy)-, methyl ester, 95.0%, 1g

2-(3-Bromophenoxy)-6-methylpyrazine, 98%, 5g

[1-(2,4-Dichloro-benzenesulfonyl)-piperidin-2-yl]-methanol, 95.0%, 250mg

2-methyltetrahydro-2H-pyrazino[1,2-a]pyrazine-1,4(3H,6H)-dione, 95.0%, 5g

4-Chloro-6-fluoro-quinoline-3-carbonitrile, 97.0%, 1g

3-(DIFLUOROMETHOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-AMINE, 95.0%, 1g

Azasetron hydrochloride, 95.0%, 1g

2,4-Dichlorobenzenesulfonyl chloride, 97.0%, 100g

tert-Butyl 1'-(4-methoxybenzyl)-2'-oxospiro[azetidine-3,3'-indoline]-1-carboxylate, 98%, 1g